Johnson & Johnson Announces FDA Approval of Tecnis PureSee IOL for Cataract Surgery

Johnson & Johnson’s TECNIS PureSee EDOF IOL cleared for US market

The manufacturer notes that TECNIS PureSee is the first US EDOF IOL cleared by the FDA without contrast sensitivity cautions.

Johnson & Johnson Announces FDA Approval of Tecnis PureSee IOL for Cataract Surgery

Key Takeaways The FDA approved Johnson & Johnson’s Tecnis PureSee IOL, an extended depth of focus IOL  Clinical data show 97% of patients reported no very bothersome visual disturbances, while the lens maintains contrast sensitivity comparable to an aspheric monofocal IOL Tecnis PureSee IOL addresses both cataract-related vision loss and presbyopia in a single surgical procedure The FDA has approved Johnson & Johnson's Tecnis PureSee ext…